Literature DB >> 8747536

The neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF-kappa B.

N Mohan1, K Sadeghi, R J Reiter, M L Meltz.   

Abstract

Recently, the neurohormone melatonin was found to be a potent endogenous hydroxyl radical scavenger. Since the activation of an important transcriptional regulator, nuclear factor-kappa B (NF-kappa B) involves free radicals as second messengers, we investigated whether melatonin alters NF-kappa B expression if present during treatment of HeLa S3 cells with known activators. The results show that upon treatment of HeLa S3 cells with tumor necrosis factor-alpha or phorbol 12-myristate 13-acetate, or with ionizing radiation, there is a profound induction of NF-kappa B binding activity. If present at the time of treatment, exogenously added melatonin, at a concentration as low as 10 microM, was found to inhibit the activation of NF-kappa B by these agents. This results leads to the hypothesis that melatonin can play a role in many physiological functions through its modulation of NF-kappa B (and possibly other) transcriptional regulators.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8747536

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  33 in total

1.  Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study.

Authors:  H Aly; H Elmahdy; M El-Dib; M Rowisha; M Awny; T El-Gohary; M Elbatch; M Hamisa; A-R El-Mashad
Journal:  J Perinatol       Date:  2014-11-13       Impact factor: 2.521

2.  Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.

Authors:  Olav Albert Christophersen
Journal:  Microb Ecol Health Dis       Date:  2012-02-01

Review 3.  The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson's disease.

Authors:  Yan Shen; Xingfang Guo; Chao Han; Fang Wan; Kai Ma; Shiyi Guo; Luxi Wang; Yun Xia; Ling Liu; Zhicheng Lin; Jinsha Huang; Nian Xiong; Tao Wang
Journal:  Cell Mol Life Sci       Date:  2017-06-16       Impact factor: 9.261

Review 4.  The melatonin immunomodulatory actions in radiotherapy.

Authors:  M Najafi; A Shirazi; E Motevaseli; Gh Geraily; F Norouzi; M Heidari; S Rezapoor
Journal:  Biophys Rev       Date:  2017-03-27

5.  The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-alpha toxicity involves membrane melatonin receptors.

Authors:  Arabinda Das; Misty McDowell; Matthew J Pava; Joshua A Smith; Russel J Reiter; John J Woodward; Abhay K Varma; Swapan K Ray; Naren L Banik
Journal:  J Pineal Res       Date:  2010-01-17       Impact factor: 13.007

Review 6.  Melatonin--a pleiotropic molecule involved in pathophysiological processes following organ transplantation.

Authors:  James E Fildes; Nizar Yonan; Brian G Keevil
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

7.  Typical cell signaling response to ionizing radiation: DNA damage and extranuclear damage.

Authors:  Hui Yu
Journal:  Chin J Cancer Res       Date:  2012-06       Impact factor: 5.087

Review 8.  Molecular mechanisms of melatonin's inhibitory actions on breast cancers.

Authors:  Sara Proietti; Alessandra Cucina; Russel J Reiter; Mariano Bizzarri
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

9.  Melatonin promotes oligodendroglial maturation of injured white matter in neonatal rats.

Authors:  Paul Olivier; Romain H Fontaine; Gauthier Loron; Juliette Van Steenwinckel; Valérie Biran; Véronique Massonneau; Angela Kaindl; Jeremie Dalous; Christiane Charriaut-Marlangue; Marie-Stéphane Aigrot; Julien Pansiot; Catherine Verney; Pierre Gressens; Olivier Baud
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.